Platelet count predicts driver mutations' co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis

Leukemia. 2021 May;35(5):1490-1493. doi: 10.1038/s41375-020-01053-9. Epub 2020 Oct 13.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Janus Kinase 2 / genetics*
  • Male
  • Middle Aged
  • Mutation / genetics*
  • Platelet Count / methods
  • Primary Myelofibrosis / genetics*
  • Primary Myelofibrosis / pathology*
  • Thrombocythemia, Essential / genetics*
  • Thrombocythemia, Essential / pathology*

Substances

  • JAK2 protein, human
  • Janus Kinase 2